CB Scientific, Inc.

OTC:CBSC

0.1347 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Revenue 0.1350.0820.0760.0320.1220.0590.0370.033
Cost of Revenue 00.0420.1490.010.720.0440.4150.227
Gross Profit 0.1350.04-0.0740.023-0.5980.015-0.378-0.194
Gross Profit Ratio 10.487-0.9750.698-4.9050.253-10.326-5.9
Reseach & Development Expenses 0.420.485000000
General & Administrative Expenses 1.3112.1421.7972.9580000
Selling & Marketing Expenses 0000000.0890.16
SG&A 1.3112.1421.7972.9580.3180.0770.0890.16
Other Expenses 0000-0.0830-0.014-0.015
Operating Expenses 1.7312.1421.7972.9650.4010.0770.1030.175
Operating Income -1.596-2.102-1.871-2.943-0.999-0.063-0.481-0.37
Operating Income Ratio -11.815-25.507-24.754-90.715-8.197-1.067-13.149-11.222
Total Other Income Expenses Net -0.035-0.005-4.471-1.38500-0.65-0.016
Income Before Tax -1.63-2.107-6.342-4.328-0.999-0.063-1.131-0.386
Income Before Tax Ratio -12.071-25.564-83.919-133.414-8.197-1.066-30.903-11.715
Income Tax Expense 0-0.2281.5440.344-0.172-0-0-0
Net Income -1.63-2.107-6.342-4.328-0.999-0.063-1.131-0.386
Net Income Ratio -12.071-25.564-83.919-133.414-8.197-1.066-30.903-11.715
EPS -0.012-0.018-0.07-0.056-0.017-0.001-0.02-0.007
EPS Diluted -0.012-0.018-0.07-0.056-0.017-0.001-0.02-0.007
EBITDA -1.625-2.101-4.798-3.977-0.999-0.06-1.128-0.369
EBITDA Ratio -12.032-25.501-63.484-122.592-8.197-1.015-30.812-11.207